logo
episode-header-image
Aug 2024
21m 14s

Renal Cell Carcinoma

JAMA NETWORK
About this episode

Renal cell carcinoma has an estimated lifetime prevalence of 2.3% for men and 1.3% for women in the US. Affected patients in early stages can have >94% cancer-specific survival. Author William Y. Kim, MD, of the University of North Carolina joins JAMA Associate Editor David L. Simel, MD, MHS, to discuss the epidemiology, clinical presentation, pathophysiology, and management of renal cell carcinoma. Related Content:

Up next
Aug 18
Diagnosis and Treatment of Hemorrhoidal Disease
Hemorrhoidal disease, pathology of the tissue lining the anal canal, affects approximately 10 million individuals in the US. Author Jean H. Ashburn, MD, of Wake Forest University School of Medicine and JAMA Senior Editor Karen E. Lasser, MD, MPH, discuss the current evidence on t ... Show More
18m 40s
Aug 13
Treatment of Complicated Staphylococcus aureus Bacteremia
Dalbavancin, a long-acting IV lipoglycopeptide, may be an option for the treatment of complicated Staphylococcus aureus bacteremia without requiring long-term IV access. Author Thomas L. Holland, MD, MSc, from Duke University School of Medicine discusses key points of the DOTS ra ... Show More
11m 35s
Aug 11
Diagnosis and Management of Prostatitis
Prostatitis affects approximately 9.3% of men in their lifetime and includes acute and chronic bacterial infection and nonbacterial chronic prostatitis with chronic pelvic pain syndrome. Author Minh N. Pham, MD, from University of North Carolina School of Medicine discusses this ... Show More
17m 51s
Recommended Episodes
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
56m 23s
Nov 2023
S2 Episode 6: Rare Disease: Is It Membranous Nephropathy?
Join experts Drs Matthew Sparks and Laurence Beck as they discuss the diagnosis and management of membranous nephropathy, a rare kidney disease. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991606). The topics and ... Show More
29m 23s
Oct 2023
S2 Episode 5: When Is It Time to Talk About Kidney Transplantation?
Join experts Drs Matthew Sparks and Samira Farouk as they pull back the curtain to help patients and providers better understand the transplant journey. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991605). The to ... Show More
28m 50s
Apr 2025
Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma
Interview with Kevin J. Contrera, MD, MPH, author of Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck Society. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neoadjuvant Therapy for Mucosal Head and Neck Squamous ... Show More
12m 19s
Nov 2024
Surgical Oncology, Part 1
In this first episode of a two-part series on surgical oncology, host Rick Greene, MD, FACS, is joined by Drs. John Stewart and Prakash Pendalai to discuss the genetic and molecular features of cancer. They also discuss screening methods and other preventive interventions, with a ... Show More
28m 14s
Jul 21
Clinical Challenges in Colorectal Surgery: Early Onset Colorectal Cancer
The incidence of early onset colorectal cancer (EOCRC) has been rising prompting the change in change in screening guidelines to 45 years of age for average risk patients. Join us for an in-depth discussion with guest speakers Dr. Andrea Cercek and Dr. Nancy You, where we provide ... Show More
38m 35s
Jan 2025
Malignant Renal Tumors
Hosts Drs. Craig Peters and Lou Kavoussi interviewDr. Stephen Campbell, discussing the most recent iteration of his chapter on current treatment approaches for malignant renal tumors. The updated chapter will appear in the forthcoming 13th edition of Campbell-Walsh-Wein Urology.D ... Show More
27m 22s
Nov 2022
American Thyroid Association Guidelines and Management of Papillary Thyroid Carcinoma
Interview with Babak Givi, MD, author of American Thyroid Association Guidelines and National Trends in Management of Papillary Thyroid Carcinoma. Hosted by Paul C. Bryson, MD, MBA. Related Content: American Thyroid Association Guidelines and National Trends in Management of Papi ... Show More
16m 17s
Jan 2025
Brentuximab vedotin, nivolumab, and chemotherapy in classical Hodgkin lymphoma; type 1 interferon signaling in sickle cell disease; and type 1 human leukocyte antigen gene mutations in cutaneous T-cel
In this week's episode we’ll learn more about an experimental regimen for classical Hodgkin lymphoma that combines brentuximab vedotin, nivolumab, and chemotherapy; a possible role for type 1 interferon signaling in developing autoantibodies to red blood cells in sickle cell dise ... Show More
21m 35s
Feb 2025
Urinary Lithiasis: Etiology, Epidemiology, and Pathogenesis
Hosts Drs. Craig Peters and Lou Kavoussi speak with Drs. Margaret Pearle and Jodi Antonelli, who have co-authored the chapter on Urinary Lithiasis in the forthcoming 13th edition of Campbell-Walsh-Wein Urology. The authors discuss the latest trends and challenges in the managemen ... Show More
34m 32s
Listen to millions of songs and podcasts on Anghami